Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”

por Holko, Przemysław
Publicado 2017

Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR(®) TS

por Holko, Przemyslaw, Kawalec, Pawal
Publicado 2011

A Comment on Craig et al.: ‘‘Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization: A NICE Single Tech...

por Holko, Przemysław, Kawalec, Paweł
Publicado 2013

Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patie...

por Kawalec, Paweł, Holko, Przemysław, Paszulewicz, Anna
Publicado 2013

Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist

por Holko, Przemysław, Kawalec, Paweł, Pilc, Andrzej
Publicado 2018

Impact of Biologic Treatment of Crohn’s Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland

por Holko, Przemysław, Kawalec, Paweł, Pilc, Andrzej
Publicado 2018

Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis

por Krawczyk, Kinga, Śladowska, Katarzyna, Holko, Przemysław, Kawalec, Paweł
Publicado 2023

Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis

por Kawalec, Paweł, Paszulewicz, Anna, Holko, Przemysław, Pilc, Andrzej
Publicado 2012

Health-Related Quality of Life Impairment and Indirect Cost of Crohn’s Disease: A Self-Report Study in Poland

por Holko, Przemysław, Kawalec, Paweł, Mossakowska, Małgorzata, Pilc, Andrzej
Publicado 2016

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis

por Kawalec, Paweł, Holko, Przemysław, Gawin, Małgorzata, Pilc, Andrzej
Publicado 2018

Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries

por Holko, Przemysław, Kawalec, Paweł, Sajak-Szczerba, Magdalena, Avedano, Luisa, Mossakowska, Małgorzata
Publicado 2022

Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries

por Holko, Przemysław, Kawalec, Paweł, Sajak-Szczerba, Magdalena, Avedano, Luisa, Mossakowska, Małgorzata
Publicado 2022